• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膜性肾病的动物模型:更多选择,更高相似度。

Animal models of membranous nephropathy: more choices and higher similarity.

机构信息

Department of Nephrology, the First Affiliated Hospital of Nanjing Medical University, Nanjing Medical University, Nanjing, China.

School of Life Science and Technology, China Pharmaceutical University, Nanjing, China.

出版信息

Front Immunol. 2024 Oct 21;15:1412826. doi: 10.3389/fimmu.2024.1412826. eCollection 2024.

DOI:10.3389/fimmu.2024.1412826
PMID:39497816
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11532550/
Abstract

Membranous nephropathy (MN) is an antibody-mediated autoimmune glomerular disease in which PLA2R1 is the main autoantibody. It has become the most common cause of adult nephrotic syndrome, and about one-third of patients can progress to end-stage kidney disease, but its pathogenesis is still unclear. Animal models can be used as suitable tools to study the pathogenesis and treatment of MN. The previous Heymann nephritis rat model and C-BSA animal model are widely used to study the pathogenesis of MN. However, the lack of target antigen expression in podocytes of model animals (especially rodents) restricts the application. In recent years, researchers constructed animal models of antigen-specific MN, such as THSD7A, PLA2R1, which more truly simulate the pathogenesis and pathological features of MN and provide more choices for the follow-up researchers. When selecting these MN models, we need to consider many aspects, including cost, difficulty of model preparation, labor force, and whether the final model can answer the research questions. This review is to comprehensively evaluate the mechanism, advantages and disadvantages and feasibility of existing animal models, and provide new reference for the pathogenesis and treatment of MN.

摘要

膜性肾病(MN)是一种抗体介导的自身免疫性肾小球疾病,其中 PLA2R1 是主要的自身抗体。它已成为成人肾病综合征的最常见原因,约三分之一的患者可进展为终末期肾病,但其发病机制仍不清楚。动物模型可用作研究 MN 的发病机制和治疗的合适工具。先前的 Heymann 肾炎大鼠模型和 C-BSA 动物模型被广泛用于研究 MN 的发病机制。然而,模型动物(尤其是啮齿动物)足细胞中靶抗原表达的缺乏限制了其应用。近年来,研究人员构建了抗原特异性 MN 的动物模型,如 THSD7A、PLA2R1,这些模型更真实地模拟了 MN 的发病机制和病理特征,为后续研究人员提供了更多选择。在选择这些 MN 模型时,我们需要考虑许多方面,包括成本、模型制备的难度、劳动力以及最终模型是否能够回答研究问题。本综述旨在全面评估现有动物模型的机制、优缺点和可行性,为 MN 的发病机制和治疗提供新的参考。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f4c/11532550/c53ae9c1337f/fimmu-15-1412826-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f4c/11532550/56356baebc06/fimmu-15-1412826-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f4c/11532550/c53ae9c1337f/fimmu-15-1412826-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f4c/11532550/56356baebc06/fimmu-15-1412826-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f4c/11532550/c53ae9c1337f/fimmu-15-1412826-g002.jpg

相似文献

1
Animal models of membranous nephropathy: more choices and higher similarity.膜性肾病的动物模型:更多选择,更高相似度。
Front Immunol. 2024 Oct 21;15:1412826. doi: 10.3389/fimmu.2024.1412826. eCollection 2024.
2
A Novel Insight into the Role of PLA2R and THSD7A in Membranous Nephropathy.PLA2R 和 THSD7A 在膜性肾病中的作用的新见解。
J Immunol Res. 2021 Jul 14;2021:8163298. doi: 10.1155/2021/8163298. eCollection 2021.
3
Membranous Nephropathy and Anti-Podocytes Antibodies: Implications for the Diagnostic Workup and Disease Management.膜性肾病与抗足细胞抗体:对诊断和疾病管理的影响。
Biomed Res Int. 2018 Jan 8;2018:6281054. doi: 10.1155/2018/6281054. eCollection 2018.
4
Antigen-Specific IgG Subclasses in Primary and Malignancy-Associated Membranous Nephropathy.原发性和恶性相关膜性肾病中的抗原特异性 IgG 亚类。
Front Immunol. 2018 Dec 20;9:3035. doi: 10.3389/fimmu.2018.03035. eCollection 2018.
5
Experimental models for elderly patients with membranous nephropathy: Application and advancements.老年膜性肾病患者的实验模型:应用与进展。
Exp Gerontol. 2024 Jan;185:112341. doi: 10.1016/j.exger.2023.112341. Epub 2023 Dec 8.
6
Immunological Pathogenesis of Membranous Nephropathy: Focus on PLA2R1 and Its Role.膜性肾病的免疫学发病机制:聚焦 PLA2R1 及其作用。
Front Immunol. 2019 Aug 6;10:1809. doi: 10.3389/fimmu.2019.01809. eCollection 2019.
7
Characterization of autoantibodies in primary membranous nephropathy and their clinical significance.原发性膜性肾病自身抗体的特征及其临床意义。
Expert Rev Clin Immunol. 2019 Feb;15(2):165-175. doi: 10.1080/1744666X.2019.1548934. Epub 2018 Nov 27.
8
Membranous nephropathy-one morphologic pattern with different diseases.膜性肾病——一种具有不同疾病的形态学模式。
Pflugers Arch. 2017 Aug;469(7-8):989-996. doi: 10.1007/s00424-017-2000-4. Epub 2017 May 29.
9
Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy.特发性膜性肾病中的含血小板反应蛋白1型结构域7A
N Engl J Med. 2014 Dec 11;371(24):2277-2287. doi: 10.1056/NEJMoa1409354. Epub 2014 Nov 13.
10
[Update membranous nephropathy].[更新膜性肾病]
Dtsch Med Wochenschr. 2020 Oct;145(20):1481-1485. doi: 10.1055/a-0976-8893. Epub 2020 Oct 6.

引用本文的文献

1
Depletion of myeloid-derived suppressor cells alleviates kidney damage in murine membranous nephropathy.髓源性抑制细胞的消耗可减轻小鼠膜性肾病中的肾脏损伤。
Front Immunol. 2025 Aug 27;16:1623613. doi: 10.3389/fimmu.2025.1623613. eCollection 2025.
2
The Influence of Anti-PAR 1 and Anti-ACE 2 Antibody Levels on the Course of Specific Glomerulonephritis Types.抗PAR 1和抗ACE 2抗体水平对特定类型肾小球肾炎病程的影响。
J Clin Med. 2025 May 4;14(9):3178. doi: 10.3390/jcm14093178.

本文引用的文献

1
Specific antigens in malignancy-associated membranous nephropathy.恶性肿瘤相关性膜性肾病中的特异性抗原
Front Med (Lausanne). 2024 Apr 15;11:1368457. doi: 10.3389/fmed.2024.1368457. eCollection 2024.
2
Diosgenin protects against cationic bovine serum albumin-induced membranous glomerulonephritis by attenuating oxidative stress and renal inflammation via the NF-κB pathway.薯蓣皂苷元通过 NF-κB 通路减轻氧化应激和肾脏炎症来防治阳离子牛血清白蛋白诱导的膜性肾小球肾炎。
Pharm Biol. 2024 Dec;62(1):285-295. doi: 10.1080/13880209.2024.2330602. Epub 2024 Mar 22.
3
Metformin combined with rapamycin ameliorates podocyte injury in idiopathic membranous nephropathy through the AMPK/mTOR signaling pathway.
二甲双胍联合雷帕霉素通过AMPK/mTOR信号通路改善特发性膜性肾病中的足细胞损伤。
J Cell Commun Signal. 2023 Dec;17(4):1405-1415. doi: 10.1007/s12079-023-00781-8. Epub 2023 Sep 13.
4
Introduction of a novel chimeric active immunization mouse model of PLA2R1-associated membranous nephropathy.一种新型嵌合主动免疫型 PLA2R1 相关膜性肾病小鼠模型的建立。
Kidney Int. 2023 Nov;104(5):916-928. doi: 10.1016/j.kint.2023.07.024. Epub 2023 Aug 19.
5
Pathogenicity of Human Anti-PLA 2 R1 Antibodies in Minipigs: A Pilot Study.人抗 PLA2R1 抗体在小型猪中的致病性:一项初步研究。
J Am Soc Nephrol. 2023 Mar 1;34(3):369-373. doi: 10.1681/ASN.0000000000000068. Epub 2023 Jan 5.
6
The classical pathway triggers pathogenic complement activation in membranous nephropathy.经典途径触发膜性肾病中的致病补体激活。
Nat Commun. 2023 Jan 28;14(1):473. doi: 10.1038/s41467-023-36068-0.
7
Podocyte expression of human phospholipase A2 receptor 1 causes immune-mediated membranous nephropathy in mice.足细胞表达人 PLA2R1 导致小鼠免疫介导性膜性肾病。
Kidney Int. 2023 Feb;103(2):297-303. doi: 10.1016/j.kint.2022.09.008. Epub 2022 Sep 30.
8
Complement C3a and C3a Receptor Activation Mediates Podocyte Injuries in the Mechanism of Primary Membranous Nephropathy.补体 C3a 和 C3a 受体激活介导原发性膜性肾病发病机制中的足细胞损伤。
J Am Soc Nephrol. 2022 Sep;33(9):1742-1756. doi: 10.1681/ASN.2021101384. Epub 2022 Jul 1.
9
Complement induces podocyte pyroptosis in membranous nephropathy by mediating mitochondrial dysfunction.补体通过介导线粒体功能障碍诱导膜性肾病足细胞焦亡。
Cell Death Dis. 2022 Mar 29;13(3):281. doi: 10.1038/s41419-022-04737-5.
10
Spectrum of biopsy-proven kidney diseases in northwest China: a review of 30 years of experiences.中国西北地区经活检证实的肾脏疾病谱:30 年经验回顾。
Int Urol Nephrol. 2022 Oct;54(10):2609-2616. doi: 10.1007/s11255-022-03168-7. Epub 2022 Mar 14.